Metabolic Syndrome
Conditions
Keywords
metabolic syndrome, lifestyle intervention, health promotion, mental health nurse, serious mental illness
Brief summary
The aim of this study is to evaluate the effectiveness of a lifestyle intervention, to reduce the risk of metabolic syndrome in patients with serious mental illness who receive treatment with antipsychotic medications. The hypothesis of the study is that: the application of a physical health promotion program in people with serious mental illness, who receive treatment with antipsychotic medications, carried out by a mental health nurse, will decrease the presence of metabolic syndrome and contribute to improve their quality of life.
Interventions
BEHAVIORALPhysical health promotion program
The program has 24 sessions. Each session has two parts: * first part: half an hour of theoretical content, about the Metabolic syndrome, the effect of unhealthy lifestyle, toxic habits such as smoking or drinking alcohol, dietary habits or physical activity. * Second part: 1 hour of physical activity (walk)
Sponsors
University of Barcelona
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Diagnostic of serious mental illness. * Treatment with antipsychotics. * Met at least 3 of the 5 criteria of metabolic syndrome According to the NCEP ATP III definition.
Exclusion criteria
* Medical contraindications to exercise * Admitted to hospital. * intellectual disability
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Decrease of at least 3 of the 5 criteria of metabolic syndrome | 6 months | Fasting glucose ≥110 mg/dL (or receiving drug therapy for hyperglycemia) Blood pressure ≥130/85 mm Hg (or receiving drug therapy for hypertension) Triglycerides ≥150 mg/dL (or receiving drug therapy for hypertriglyceridemia) HDL-C \<40 mg/dL in men or \<50 mg/dL in women (or receiving drug therapy for reduced HDL-C) Waist circumference ≥102 cm in men or ≥88 cm in women |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Metabolic syndrome prevalence | 6 months | expressed as a percentage |
| use of antipsychotic | 6 months | Percentage of drugs prescribed by generic name |
| Toxic habits | 6 months | Percentage of smokers percentage of people who drink alcohol percentage of people using drugs of abuse |
| Quality of life improvement | 6 months | EuroQol- 5 Dimension (EQ-5D) includes a Visual Analog Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status). |
Countries
Spain
Outcome results
None listed